Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHOSPHOR study: phosphate control and renal function in non-dialysis CKD
jRCTs041180179Completed
- Sponsor
- Torii Pharmaceutical
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ferric citrate in chronic kidney disease (CKD) and hyperphosphatemia (2 arms), sponsored by Torii Pharmaceutical. Primary endpoint: Change from baseline eGFR. Started Mar 2018; status: completed.
02
Drugs
ferric citrate
03
Conditions
chronic kidney disease (CKD)hyperphosphatemia
Beyond the preview
Go deeper on jRCTs041180179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180179.